Drug intelligence / Profile preview

yufeng ningxin

Development stage
Phase 4
Modality
Small Molecules
Administration
Oral
01

Overview

Yufeng Ningxin (YFNX) is a traditional Chinese patent medicine primarily used for the treatment of cardiovascular and cerebrovascular diseases such as essential hypertension, coronary heart disease (CHD), angina pectoris, and neuropathic headache. The main active ingredient in most Yufeng Ningxin preparations is puerarin (derived from Pueraria lobata), which is believed to relieve spasm and pain while enhancing cerebral and coronary blood flow. Clinical studies suggest that YFNX can reduce systolic and diastolic blood pressure in patients with hypertension, decrease the frequency and duration of angina attacks in CHD patients, improve electrocardiogram results, alleviate symptoms like dizziness and headache associated with high blood pressure or nervous headache (blood-stasis syndrome), and generally improve quality of life. Adverse reactions are reported to be few[1][2][5][8]. It is available in various dosage forms including tablets, capsules, granules, and dropping pills.

Brand names
Yufeng NingxinYu Feng Ning Xin Pian
Other names
YFNXYufengningxinYu Feng Ning Xin Drop PillsYu Feng Ning Xin Tablets
02

Targets

ESR2 (ERβ)NOS1 (nNOS)

Beyond the preview

Go deeper on yufeng ningxin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yufeng ningxin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call